Notification of cessation of securities - NUZ

Oct 13, 2026 at 1:37 AM EDT · Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · Oct 13, 2026 at 1:37 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-nuz-1

Release

Appendix 3H - Notification of cessation of securitiesAppendix 3H - Notification of cessation of securities1 / 4Announcement SummaryEntity nameNEURIZON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementTuesday October 13, 2026Details of +securities that have ceasedASX...

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Updated Investor Presentation and Webinar ReminderOct 6
FDA Type C Feedback, HEALEY trial potentially registrationalOct 5
Dr Chris Bremer commences as Neurizon CEOSep 30
Change of Director's Interest NoticeSep 16
Neurizon Announces Partial Redemption of Convertible NotesSep 9

Later from Neurizon Therapeutics

Change of AGM DateOct 22
Notice of Annual General Meeting/Proxy FormOct 26
Appendix 4C & Quarterly UpdateOct 27
Trading HaltOct 28
Firm commitments to raise A$4.3m and announcement of SPPNov 1

All Neurizon Therapeutics news releases

Follow Neurizon Therapeutics into a list and get an email when it puts out news.

Follow Neurizon Therapeutics